Imaging agent for pancreatic and head and neck cancers
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study tests a new imaging agent that may help see pancreatic and head and neck cancers more clearly on a PET/CT scan. It is for people newly diagnosed who have not yet started treatment, to see if the agent is safe and works well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a confirmed diagnosis of pancreatic or head and neck cancer from a biopsy.
- You have not yet started any definitive treatment like surgery, radiation, or chemotherapy for this cancer.
- You are willing and able to have a PET/CT scan.
- You must not have severe liver or kidney disease (such as needing dialysis or having serious liver failure).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging agent that helps doctors see tumors in the body. It may help find cancer or see how it spreads, which could guide treatment decisions.
This study tests a new imaging agent that may help see certain cancers (colorectal, gastric, or pancreatic) more clearly on PET scans. It may help doctors better understand your tumor and guide treatment decisions.
This study tests a new type of imaging scan (PET/CT or PET/MR) that uses a radioactive tracer to help doctors better detect and diagnose various cancers. The scan targets a specific protein found in tumors, which may help identify cancer more accurately than standard imaging.
This trial tests a new imaging method (68Ga-DOTA-mPNE PET/CT) to see if it can help detect cancers. It's for people who haven't had chemotherapy or radiation yet and will have a biopsy or surgery.
This trial uses a new imaging agent called 64Cu-DOTA A2 to help see pancreatic cancer on a PET scan. It may help doctors find cancer that has spread, without the need for surgery.
This study tests a new type of PET scan (a detailed imaging test) called [68Ga]Ga-FAPI that may help doctors see cancer better and faster than standard scans. You'll receive this experimental scan to see if it improves cancer detection before surgery.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.